Neurogene Inc. Diluted Shares Outstanding (Weighted Average)
Neurogene Inc. (NGNE) reported Diluted Shares Outstanding (Weighted Average) of 22.55 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- Neurogene Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 22.55M shares, a 7.11% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 22.31M shares, a 6.24% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 22.08M shares, a 13.42% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 21.17M shares, a 24.86% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 21.33M shares, a 21.40% increase from fiscal 2024.
- Neurogene Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 17.57M shares.
- Neurogene Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 55.22M shares, a 0.33% increase from fiscal 2021.
- Neurogene Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 55.04M shares, a 6.21% increase from fiscal 2020.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 0 month | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 22.55M shares 10-Q · filed 2026-08-11 | 22.43M shares 10-Q · filed 2026-08-11 | 22.31M shares derived: average of 3 quarters · filed 2026-08-11 | 22.03M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 22.31M shares 10-Q · filed 2026-05-12 | 22.19M shares derived: average of 2 quarters · filed 2026-05-12 | 21.85M shares derived: average of 3 quarters · filed 2026-05-12 | 21.65M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 22.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 21.63M shares derived: average of 2 quarters · filed 2026-03-24 | 21.44M shares derived: average of 3 quarters · filed 2026-08-11 | 21.33M shares 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | 21.17M shares 10-Q · filed 2025-11-13 | 21.11M shares derived: average of 2 quarters · filed 2026-08-11 | 21.07M shares 10-Q · filed 2025-11-13 | 20.67M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 21.06M shares 10-Q · filed 2026-08-11 | 21.03M shares 10-Q · filed 2026-08-11 | 20.51M shares derived: average of 3 quarters · filed 2026-08-11 | 19.62M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 21.00M shares 10-Q · filed 2026-05-12 | 20.23M shares derived: average of 2 quarters · filed 2026-05-12 | 19.14M shares derived: average of 3 quarters · filed 2026-05-12 | 18.59M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 19.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 18.21M shares derived: average of 2 quarters · filed 2026-03-24 | 17.79M shares derived: average of 3 quarters · filed 2026-03-24 | 17.57M shares 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | 16.95M shares 10-Q · filed 2025-11-13 | 16.95M shares derived: average of 2 quarters · filed 2025-11-13 | 16.93M shares 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | 16.94M shares 10-Q · filed 2025-08-11 | 16.92M shares 10-Q · filed 2025-08-11 | ||||||
| 2024-03-31 | 16.90M shares 10-Q · filed 2025-05-09 | |||||||
| 2023-12-31 | 4.66M shares 10-K · filed 2025-03-24 | |||||||
| 2023-09-30 | 446.25K shares 10-Q · filed 2024-11-18 | 11.10M shares 10-Q · filed 2023-11-14 | 445.36K shares derived: average of 2 quarters · filed 2024-11-18 | 441.50K shares 10-Q · filed 2024-11-18 | 11.22M shares 10-Q · filed 2023-11-14 | 61.02M shares derived: average of 4 quarters · filed 2024-11-18 | ||
| 2023-06-30 | 444.46K shares 10-Q · filed 2024-08-09 | 56.16M shares 10-Q · filed 2023-08-10 | 439.07K shares 10-Q · filed 2024-08-09 | 55.79M shares 10-Q · filed 2023-08-10 | 81.21M shares derived: average of 3 quarters · filed 2024-08-09 | 63.67M shares derived: average of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 55.42M shares 10-Q · filed 2023-05-08 | 121.59M shares derived: average of 2 quarters · filed 2023-05-08 | 84.75M shares derived: average of 3 quarters · filed 2023-11-14 | 77.36M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-12-31 | 187.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 99.41M shares derived: average of 2 quarters · filed 2023-11-14 | 84.67M shares derived: average of 3 quarters · filed 2023-11-14 | 55.22M shares 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | 11.05M shares 10-Q · filed 2023-11-14 | 55.25M shares 10-Q · filed 2022-11-14 | 33.13M shares derived: average of 2 quarters · filed 2023-11-14 | 11.04M shares 10-Q · filed 2023-11-14 | 55.20M shares 10-Q · filed 2022-11-14 | 44.13M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 55.20M shares 10-Q · filed 2023-08-10 | 55.17M shares 10-Q · filed 2023-08-10 | 55.15M shares derived: average of 3 quarters · filed 2023-08-10 | 55.14M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 55.14M shares 10-Q · filed 2023-05-08 | 55.13M shares derived: average of 2 quarters · filed 2023-05-08 | 55.11M shares derived: average of 3 quarters · filed 2023-05-08 | 55.09M shares derived: average of 4 quarters · filed 2023-05-08 | ||||
| 2021-12-31 | 55.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 55.10M shares derived: average of 2 quarters · filed 2023-03-20 | 55.07M shares derived: average of 3 quarters · filed 2023-03-20 | 55.04M shares 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | 55.09M shares 10-Q · filed 2022-11-14 | 55.06M shares derived: average of 2 quarters · filed 2022-11-14 | 55.02M shares 10-Q · filed 2022-11-14 | 54.92M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 55.03M shares 10-Q · filed 2022-08-09 | 54.99M shares 10-Q · filed 2022-08-09 | 54.86M shares derived: average of 3 quarters · filed 2022-08-09 | 54.68M shares derived: average of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | 54.94M shares 10-Q · filed 2022-05-09 | 54.78M shares derived: average of 2 quarters · filed 2022-05-09 | 54.56M shares derived: average of 3 quarters · filed 2022-05-09 | 53.27M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | 54.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 54.37M shares derived: average of 2 quarters · filed 2022-03-01 | 52.71M shares derived: average of 3 quarters · filed 2022-03-01 | 51.83M shares 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | 54.12M shares 10-Q · filed 2021-11-04 | 51.76M shares derived: average of 2 quarters · filed 2021-11-04 | 50.90M shares 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | 49.39M shares 10-Q · filed 2021-08-05 | 49.28M shares 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | 49.17M shares 10-Q · filed 2021-05-12 | |||||||
| 2019-06-30 | 23.54M shares 10-Q · filed 2019-08-01 | 23.54M shares 10-Q · filed 2019-08-01 | ||||||
| 2018-06-30 | 23.85M shares 10-Q · filed 2019-08-01 | 23.50M shares 10-Q · filed 2019-08-01 | ||||||
| 2017-06-30 | 23.44M shares 10-Q · filed 2018-08-08 | 23.43M shares 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |